Evaluation of Consistency of Treatment Response Across Regions—the LEADER Trial in Relation to the ICH E17 Guideline

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

(2019) Hertzel C Gerstein et al.   LANCET

Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials

(2019) Edoardo Mannucci et al.   DIABETES OBESITY & METABOLISM

Geographic Variations in Controlled Trials

(2017)   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies

(2016) Manel Pladevall et al.   BMC Cardiovascular Disorders

Geographic variations in the PARADIGM-HF heart failure trial

(2016) Søren Lund Kristensen et al.   EUROPEAN HEART JOURNAL

Interpreting Geographic Variations in Results of Randomized, Controlled Trials

(2016) Salim Yusuf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Geographic differences in heart failure trials

(2015) João Pedro Ferreira et al.   EUROPEAN JOURNAL OF HEART FAILURE

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial

(2013) Steven P. Marso et al.   AMERICAN HEART JOURNAL

Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials

(2012) Hui Quan et al.   STATISTICS IN MEDICINE

Aspirin Dose and Ticagrelor Benefit in PLATO: Fact or Fiction?

(2011) Victor L. Serebruany   CARDIOLOGY

Liraglutide in clinical practice: dosing, safety and efficacy

(2010) G. E. Peterson et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE